Whale Large Capital
  • Politics
  • World News
  • Business
  • Investing
  • Politics
  • World News
  • Business
  • Investing

Whale Large Capital

Politics

Dr. Oz bats back Democratic attempts to paint him as a ‘snake oil’ salesman in Senate hearing

by March 14, 2025
March 14, 2025
Dr. Oz bats back Democratic attempts to paint him as a ‘snake oil’ salesman in Senate hearing

Dr. Mehmet Oz was slammed by his detractors during a Senate confirmation hearing Friday on Capitol Hill for promoting unproven alternative health treatments, and one Democrat called it the ‘most ludicrous wellness grifting’ he’d ever seen.   

Oz laid out his plans for the agency, including potential reforms he is considering, during a confirmation hearing in front of the Senate Committee on Finance. The committee will soon vote on whether to advance Oz’s nomination to become the next director of the Center for Medicare and Medicaid Services to the full Senate. 

While Oz’s medical expertise was not widely challenged Friday, his motivations were. Dubbed ‘America’s Doctor’ by Oprah Winfrey, Oz used his TV platform at times to promote alternative health remedies, endorsing questionable weight loss solutions like green coffee extract and raspberry ketones.

Sen. Maggie Hassan, D-N.H., sought to get Oz to admit that his promotion of certain supplements for weight loss, such as green coffee extract, were fraudulent. While Oz admitted green coffee extract is not a miracle weight loss drug, he argued that he never promoted it as such. 

‘There are many things I said on the show. I take great pride in the research we did at the time to identify which of these worked and which ones didn’t. Many of them are still being researched, like the green coffee bean extract you just mentioned,’ Oz told Hassan. The senator then inquired how much he was paid to promote these products, and Oz responded that he got nothing.

But Oz’s claim he wasn’t getting paid to promote the products didn’t convince Hassan, who pointed out press reports chronicling the ‘Dr. Oz effect,’ a phenomenon whereby sales of products he endorsed would skyrocket after being featured on his show. 

‘That was written about by the press,’ Oz told Hassan. Hassan then argued Oz seemed ‘unwilling to take accountability for [his] promotion of snake oil remedies.’

Oz’s financial ties to a litany of companies spanning many corners of the healthcare sector, including nutrition supplements, has been a point of scrutiny for his detractors. In an ethics filing submitted in advance of the hearing, Oz indicated he would divest his holdings in more than 70 companies and investment funds that could pose potential conflicts of interest.

One of those companies is iHerb, an online supplement retailer, which represents one of Oz’s largest financial holdings. According to his ethics filing, Oz’s holdings in iHerb are worth as much as $25 million.  

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates healthcare providers get paid for their services. Oz, if confirmed, could theoretically take action to get federal healthcare programs, like Medicaid and Medicare, to cover a greater number of supplements not already covered. 

A committee vote to decide whether to send Oz to the full Senate has not yet been scheduled. He will need to garner at least 50 votes in the full Senate to be confirmed.

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Feds accused of destroying Epstein evidence put on notice by GOP firebrand
next post
Biden White House turned over Trump, Pence government cellphones to FBI as part of anti-Trump agent’s case

You may also like

When Biden-Harris abandoned American hostages, they desecrated the...

October 13, 2024

‘Star Wars’ actor Mark Hamill weighs in on...

August 22, 2024

SCOOP: Jim Jordan joining Trump at NCAA men’s...

March 21, 2025

Harris campaign ‘internal worries about cohesiveness’ surface: report

August 29, 2024

Senate to vote on key Trump nominee after...

February 6, 2025

Justice Department fires more than a dozen key...

January 27, 2025

Top conservative group vows to ‘work closely’ with...

February 27, 2025

Complex partial seizure ruled as cause of pausing...

February 12, 2025

Trump’s plan to slash ‘woke’ foreign aid, NPR...

June 12, 2025

House Democrat announces articles of impeachment against Trump:...

April 29, 2025

    Subscribe today to receive exclusive access to all our retirement secrets and income strategies, including special financial news and updates from our experts. From time to time, our newsletters feature valuable insights and analysis on the latest financial trends. Don't miss out on these exclusive updates – join our subscription to stay informed!


    By opting in you agree to receive emails from us. Your information is secure and your privacy is protected.



    Latest

    • Netanyahu calls on Iranian citizens to seize ‘opportunity’ for regime change

      June 15, 2025
    • Israel’s actions against Iran create strategic opportunity for US in nuclear talks, experts say

      June 14, 2025
    • Israel strikes at the heart of Iran’s nuclear ambitions in Isfahan offensive

      June 14, 2025
    • Time for Israel to take out ‘head of the snake,’ target members of Iranian regime, says former IDF intel chief

      June 14, 2025
    • Israel attacked three key Iranian nuclear facilities. Did it strike a decisive blow?

      June 14, 2025
    • Israeli official vows ‘We have more surprises coming up’ for Iran following wave of airstrikes

      June 14, 2025

    Categories

    • Business (672)
    • Investing (661)
    • Politics (4,497)
    • World News (3,019)
    • Terms & Conditions
    • Privacy Policy
    • Contact us
    • About us

    Disclaimer: WhaleLargeCapital.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 WhaleLargeCapital.com | All Rights Reserved